$8.42
Febrile neutropenia is a severe side effect of cancer treatment drugs, posing a potentially life-threatening complication and considered an oncological emergency. Recent advancements in supportive therapy have improved the prevention and treatment of (febrile) neutropenia, enabling the avoidance of dose reductions and cycle delays in chemotherapy. This leads to enhanced patient survival.
This updated edition delves into the fundamentals of neutropenia, infectious aspects, and the application of hematopoietic growth factors. The aim is to provide clinical practitioners with a quick insight into current practices for managing neutropenic patients.
Product Details
Publisher: UNI-MED
Edition: 3rd, revised edition (20 May 2022)
Language: German
ISBN-10: 3837424391
ISBN-13: 978-3837424393
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline